MedTrace Logo

Web and Mobile Smoking Cessation

NCT01952236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1266

Last updated 2019-02-12

No results posted yet for this study

Summary

This study seeks to develop and then perform a controlled efficacy Randomized Controlled Trial assessing tobacco abstinence of a best-practices Web-based PC-delivered smoking cessation intervention (QuitOnline) compared to a Mobile Smartphone-delivered intervention (MobileQuit). Study participants are randomized to one of two conditions: a Web Only intervention and the Web+Mobile intervention. The hypothesis is that the Web+Mobile approach will yield greater efficacy than the Web Only condition.

Conditions

  • Smoking

Interventions

BEHAVIORAL

Web+Mobile

We propose to evaluate the efficacy and acceptability of a Web+Mobile tobacco cessation intervention in a 2-arm Randomized Controlled Trial with 1,271 adult study participants who agree to quit smoking within a pre-specified amount of time. Participants who meet eligibility criteria will be randomly assigned to either (a) an enhanced Web Only intervention or (b) an enhanced Web+Mobile intervention.

BEHAVIORAL

Web Only

A Web-based PC-delivered best practices smoking cessation intervention.

Sponsors & Collaborators

  • Oregon Research Institute

    lead OTHER

Principal Investigators

  • Brian G Danaher, PhD · Oregon Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-10-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952236 on ClinicalTrials.gov